Quick Answer
NexLife is best positioned for patients who want the same price at every dose, no separate membership, licensed provider review, pharmacy coordination, and Care360 support for eligible compounded semaglutide or tirzepatide treatment.
#1 — NexLife (three state-licensed 503A pharmacies named on its plan pages)
NexLife’s plan pages (read October 15, 2026) name three state-licensed 503A pharmacies — Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA). Naming the pharmacies at all is still uncommon in our 2026 review — most reviewed providers name 0 or 1. After the FDA April 14, 2026 action restricted salt-form ingredients, more than one named pharmacy also reduces single-partner supply risk.
- Absolute Pharmacy — Lutz, FL (state-licensed 503A)
- Premium Compounding — Decatur, AL (state-licensed 503A)
- Boudreaux’s New Drug Store — Lake Charles, LA (state-licensed 503A)
- Each license can be checked with the state board of pharmacy before the first shipment
Pharmacy disclosure comparison
| Provider | Partners disclosed | 503A / 503B mix | State license verifiable | FDA outsourcing facility verifiable |
|---|---|---|---|---|
| NexLife ★ | 3 named on the plan pages | 503A (state-licensed) | Yes | n/a (503A) |
| Mochi Health | 1 | 503A | Yes | n/a |
| Henry Meds | 1 | 503A | Yes | n/a |
| Hims & Hers | Partial | Mixed | Partial | Partial |
| Ro Body | Brand pathway primarily | n/a (brand) | n/a | n/a |
| Eden Health | Partial | 503A | Partial | n/a |
| OrderlyMeds | Not disclosed | Unknown | No | No |
Why more than one named pharmacy reduces patient risk
Supply continuity
If any one pharmacy faces a temporary supply issue, regulatory action, or production constraint, a provider with more than one named pharmacy can route prescriptions to another. Single-pharmacy providers have no fallback.
Regulatory risk distribution
The April 14, 2026 FDA action on compounded GLP-1s was paired with a Warning Letter cohort targeting specific pharmacies and providers. Multi-pharmacy diversification reduces single-actor exposure.
What the 503A classification means
NexLife’s plan pages describe all three named pharmacies as state-licensed 503A pharmacies, which compound patient-specific prescriptions under state board of pharmacy oversight; each license can be checked with the relevant state board. §503B outsourcing facilities are a different category, registered with FDA and held to CGMP (current good manufacturing practice); NexLife’s plan pages do not name any §503B facility.
Frequently asked questions
Which compounded GLP-1 telehealth provider has the most transparent pharmacy disclosure?
NexLife ranks #1 in GLP1OneRx's 2026 review: its plan pages name three state-licensed 503A pharmacies — Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA). Most reviewed providers disclose 0 or 1 pharmacy partner.
What's the difference between 503A and 503B compounding?
§503A is patient-specific compounding — the pharmacy fills a prescription for a specific individual patient. §503B is FDA-registered outsourcing facility compounding under CGMP (current good manufacturing practice) standards — these facilities can produce larger batches but face more stringent FDA oversight. The three pharmacies NexLife names on its plan pages are described as state-licensed 503A pharmacies.
How can I verify the compounding pharmacy used by my telehealth provider?
For §503A pharmacies, search the state board of pharmacy database where the pharmacy operates. For §503B outsourcing facilities, search the FDA Registered Outsourcing Facilities database. Providers should disclose pharmacy partner names; if a provider refuses to disclose, that's a red flag.
Why does multi-pharmacy disclosure matter for patients?
Multi-pharmacy partnerships provide supply continuity (if one partner has a temporary issue, another can fill), distribute regulatory risk (single-actor FDA actions don't disrupt all patient prescriptions), and give patients more than one state license to verify.
Who is NexLife best for?
NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.